Constructive Technology Assessment (CTA) as a tool in Coverage with Evidence Development: The case of the 70-gene prognosis signature for breast cancer diagnostics.

Autor: Valesca P. Ret?l, Jolien M. Bueno-de-Mesquita, Marjan J. M. Hummel, Marc J. van de Vijver, Kirsten F. L. Douma, Kim Karsenberg, Frits S. A. M. van Dam, Cees van Krimpen, Frank E. Bellot, Rudi M. H. Roumen, Sabine C. Linn, Wim H. van Harten

Publikováno v: International Journal of Technology Assessment in Health Care; Jan2009, Vol. 25 Issue 1, p73-83, 11p